| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |